{"ModuleTitle": "Company Description", "CompanyName": "Avidity Biosciences, Inc.", "Symbol": "RNA", "Address": "10975 N. TORREY PINES RD., #150, LA JOLLA, California, 92037, United States of America", "Phone": "858-401-7900", "Industry": "Major Pharmaceuticals", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "We are pioneering a new class of oligonucleotide-based therapies called Antibody\r\nOligonucleotide Conjugates (AOCs) designed to overcome the current limitations\r\nof oligonucleotide therapies in order to treat a wide range of serious diseases.\r\nWe utilize our proprietary AOC platform to design, engineer and develop\r\ntherapeutics that combine the tissue selectivity of monoclonal antibodies (mAbs)\r\nand the precision of oligonucleotide therapies in order to access previously\r\nundruggable tissue and cell types and more effectively target underlying genetic\r\ndrivers of diseases. We are initially focused on muscle diseases to demonstrate\r\nthe capabilities of our AOCs, and our muscle franchise consists of five\r\nprograms. Our lead product candidate, AOC 1001, is designed to treat myotonic\r\ndystrophy type 1 (DM1), a rare monogenic muscle disease.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f06%2f11%2f0001193125-20-166063.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [], "Number_of_employees": ["NO INFO"], "Subsidiaries": ["NO INFO"]}